Tango Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Third Rock Ventures has significantly reduced its beneficial ownership in Tango Therapeutics, Inc., now holding approximately 5.85% of common stock.
NASDAQ
Third Rock Ventures has significantly reduced its beneficial ownership in Tango Therapeutics, Inc. to 6.97% through multiple open market dispositions.
NASDAQ
SCHEDULE 13D/A: Boxer Capital Entities Restructure Holdings in Tango Therapeutics, Aaron Davis Maintains 10% Stake
An amendment to Schedule 13D reveals a restructuring of beneficial ownership in Tango Therapeutics, Inc., with BCTG Holdings, LLC distributing its shares to MVA Investors, LLC and Boxer Capital Management, LLC, while Aaron I. Davis's aggregate beneficial ownership remains at approximately 10%.